Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy - Update regarding the thiazolidinediones

被引：87

作者：

Nathan, D. M. ^{[1
]}

Buse, J. B.

Davidson, M. B.

Ferrannini, E.

Holman, R. R.

Sherwin, R.

Zinman, B.

机构：

[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA

[2] Univ N Carolina, Sch Med, Chapel Hill, NC USA

[3] Univ Pisa, Dept Internal Med, Pisa, Italy

[4] Univ Oxford, Oxford Ctr Endocrinol & Metab, Diabet Trials Unit, Oxford, England

[5] Yale Univ, Sch Med, New Haven, CT USA

[6] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada

来源：

DIABETOLOGIA | 2008年 / 51卷 / 01期

关键词：

D O I：

10.1007/s00125-007-0873-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：8 / 11

页数：4

共 17 条

[1] Rosiglitazone - Continued uncertainty about safety [J].

Drazen, Jeffrey M. ;

Morrissey, Stephen ;

Curfman, Gregory D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :63-64

[2]

*GALAXOSMITHKLINE, 2007, ADV COMM BRIEF DOC C, P40

[3] Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [J].

Home, Philip D. ;

Pocock, Stuart J. ;

Beck-Nielsen, Henning ;

Gomis, Ramon ;

Hanefeld, Markolf ;

Jones, Nigel P. ;

Komajda, Michel ;

McMurray, John J. V. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :28-38

[4] Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].

Kahn, Steven E. ;

Haffner, Steven M. ;

Heise, Mark A. ;

Herman, William H. ;

Holman, Rury R. ;

Jones, Nigel P. ;

Kravitz, Barbara G. ;

Lachin, John M. ;

O'Neill, M. Colleen ;

Zinman, Bernard ;

Viberti, Giancarlo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443

[5] Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials [J].

Lago, Rodrigo M. ;

Singh, Premranjan P. ;

Nesto, Richard W. .

LANCET, 2007, 370 (9593) :1129-1136

[6] Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials [J].

Lincoff, A. Michael ;

Wolski, Kathy ;

Nicholls, Stephen J. ;

Nissen, Steven E. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10) :1180-1188

[7] Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes [J].

Nathan, D. M. ;

Buse, J. B. ;

Davidson, M. B. ;

Heine, R. J. ;

Holman, R. R. ;

Sherwin, R. ;

Zinman, B. .

DIABETOLOGIA, 2006, 49 (08) :1711-1721

[8] Rosiglitazone and cardiotoxicity - Weighing the evidence [J].

Nathan, David M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :64-66

[9] Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes [J].

Nathan, David M. ;

Buse, John B. ;

Davidson, Mayer B. ;

Heine, Robert J. ;

Holman, Rury R. ;

Sherwin, Robert ;

Zinman, Bernard .

DIABETES CARE, 2006, 29 (08) :1963-1972

[10] Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].

Nissen, Steven E. ;

Wolski, Kathy .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471

← 1 2 →